<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36589958</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Design and recruitment of a large-scale cohort study on prevalence, risk factors and impact evaluation of post-COVID-19 condition and its wider long-term social, mental, and physical health impact: The PRIME post-COVID study.</ArticleTitle><Pagination><StartPage>1032955</StartPage><MedlinePgn>1032955</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1032955</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2022.1032955</ELocationID><Abstract><AbstractText Label="BACKGROUND">Persistent symptoms, described as long COVID or post-COVID-19 condition, pose a potential public health problem. Here, the design and recruitment of the PRIME post-COVID study is described. PRIME post-COVID is a large-scale population-based observational study that aims to improve understanding of the occurrence, risk factors, social, physical, mental, emotional, and socioeconomic impact of post-COVID-19 condition.</AbstractText><AbstractText Label="METHODS">An observational open cohort study was set up, with retrospective and prospective assessments on various health-conditions and health-factors (medical, demographic, social, and behavioral) based on a public health COVID-19 test and by self-report (using online questionnaires in Dutch language). Invited for participation were, as recorded in a public health registry, adults (18 years and older) who were tested for COVID-19 and had a valid Polymerase Chain Reaction (PCR) positive or negative test result, and email address. In November 2021, 61,655 individuals were invited by email to participate, these included all eligible adults who tested PCR positive between 1 June 2020 and 1 November 2021, and a sample of adults who tested negative (2:1), comparable in distribution of age, sex, municipality of residence and year-quarter of testing. New recruitment periods are planned as well. Participants are followed over time by regular follow-up measurements. Data are analyzed using the appropriate data-analyses methods.</AbstractText><AbstractText Label="DISCUSSION">The PRIME post-COVID study will provide insights into various health-related aspects of post-COVID-19 condition in the context of various stages of the COVID-19 pandemic. Results will inform practical guidance for society, clinical and public health practice for the prevention and care for long-term impact of COVID-19.</AbstractText><AbstractText Label="TRIAL REGISTRATION CLINICALTRIALSGOV IDENTIFIER">NCT05128695.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Pagen, van Bilsen, Brinkhues, Moonen, Van Herck, Konings, den Heijer, Mujakovic, ter Waarbeek, Bouwmeester-Vincken, Vaes, Spruit, Hoebe and Dukers-Muijrers.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pagen</LastName><ForeName>Demi M E</ForeName><Initials>DME</Initials><AffiliationInfo><Affiliation>Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Department of Social Medicine, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bilsen</LastName><ForeName>C&#xe9;line J A</ForeName><Initials>CJA</Initials><AffiliationInfo><Affiliation>Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Department of Social Medicine, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brinkhues</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Knowledge and Innovation, South Limburg Public Health Service, Heerlen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moonen</LastName><ForeName>Chrissy P B</ForeName><Initials>CPB</Initials><AffiliationInfo><Affiliation>Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Department of Social Medicine, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Herck</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Research and Education, Ciro, Horn, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nutrition and Translational Research in Metabolism (NUTRIM), Department of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Rehabilitation Research Center (REVAL), BIOMED-Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konings</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Process and Information Management, Communication and Automation, South Limburg Public Health Service, Heerlen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>den Heijer</LastName><ForeName>Casper D J</ForeName><Initials>CDJ</Initials><AffiliationInfo><Affiliation>Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Department of Social Medicine, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mujakovic</LastName><ForeName>Suhreta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Process and Information Management, Communication and Automation, South Limburg Public Health Service, Heerlen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ter Waarbeek</LastName><ForeName>Henri&#xeb;tte L G</ForeName><Initials>HLG</Initials><AffiliationInfo><Affiliation>Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouwmeester-Vincken</LastName><ForeName>Noortje</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, North Limburg Public Health Service, Venlo, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaes</LastName><ForeName>Anouk W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Research and Education, Ciro, Horn, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spruit</LastName><ForeName>Martijn A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Research and Education, Ciro, Horn, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nutrition and Translational Research in Metabolism (NUTRIM), Department of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoebe</LastName><ForeName>Christian J P A</ForeName><Initials>CJPA</Initials><AffiliationInfo><Affiliation>Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Department of Social Medicine, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Department of Medical Microbiology, Maastricht University Medical Centre+, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dukers-Muijrers</LastName><ForeName>Nicole H T M</ForeName><Initials>NHTM</Initials><AffiliationInfo><Affiliation>Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Care and Public Health Research Institute (CAPHRI), Department of Health Promotion, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05128695</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">physical health</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">socioeconomic impact</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>2</Day><Hour>4</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36589958</ArticleId><ArticleId IdType="pmc">PMC9799054</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2022.1032955</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. Coronavirus (COVID-19) Dashboard. Geneva: World Health Organization  (2020). Available online at: https://covid19.who.int/ (accessed August 30, 2022).</Citation></Reference><Reference><Citation>WHO. Coronavirus Disease (COVID-19). Geneva: World Health Organization  (2020). Available online at: https://www.who.int/health-topics/coronavirus#tab=tab_3 (accessed January 20, 2022).</Citation></Reference><Reference><Citation>Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. . Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. (2020) 20:669&#x2013;77. 10.1016/S1473-3099(20)30243-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30243-7</ArticleId><ArticleId IdType="pmc">PMC7158570</ArticleId><ArticleId IdType="pubmed">32240634</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese center for disease control and prevention. JAMA. (2020) 323:1239&#x2013;42. 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. (2020) 11:1&#x2013;13. 10.1186/s13293-020-00304-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-020-00304-9</ArticleId><ArticleId IdType="pmc">PMC7247289</ArticleId><ArticleId IdType="pubmed">32450906</ArticleId></ArticleIdList></Reference><Reference><Citation>Grint DJ, Wing K, Williamson E, McDonald HI, Bhaskaran K, Evans D, et al. . Case fatality risk of the SARS-CoV-2 variant of concern B. 11 7 in England, 16 November to 5 February. Eurosurveillance. (2021) 26:2100256. 10.2807/1560-7917.ES.2021.26.11.2100256</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.11.2100256</ArticleId><ArticleId IdType="pmc">PMC7976383</ArticleId><ArticleId IdType="pubmed">33739254</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CJ. COVID-19 will continue but the end of the pandemic is near. Lancet. (2022) 399:417&#x2013;9. 10.1016/S0140-6736(22)00100-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00100-3</ArticleId><ArticleId IdType="pmc">PMC8769657</ArticleId><ArticleId IdType="pubmed">35065006</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YM, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FV, et al. . Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. (2020) 6:542. 10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Go&#xeb;rtz YM, Van Herck M, Machado FV, Meys R, Delbressine JM, et al. . Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ Open Res. (2021) 7:141. 10.1183/23120541.00141-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00141-2021</ArticleId><ArticleId IdType="pmc">PMC8012818</ArticleId><ArticleId IdType="pubmed">34041295</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long Covid. Soc Sci Med. (2021) 268:113426. 10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. Br Med J. (2020) 370:m3489. 10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. (2021) 53:737&#x2013;54. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus.Geneva: World Health Organization  (2021). Available online at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (accessed October 6, 2021).</Citation></Reference><Reference><Citation>Rajan S, McKee M, Hern&#xe1;ndez-Quevedo C, Karanikolos M, Richardson E, Webb E, et al. . What have European countries done to prevent the spread of COVID-19? Lessons from the COVID-19 health system response monitor. Health Policy. (2022) 126:355&#x2013;61. 10.1016/j.healthpol.2022.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2022.03.005</ArticleId><ArticleId IdType="pmc">PMC8912990</ArticleId><ArticleId IdType="pubmed">35339282</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares D, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, Jongh P-D, et al. . Long COVID: pathophysiology&#x2013;epidemiology and patient needs. Health Serv Res. (2021) 344:281.</Citation></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. (2021) 8:416&#x2013;27. 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z, Ladhani SN. Causation or confounding: why controls are critical for characterizing long COVID. Nat Med. (2021) 27:1129&#x2013;30. 10.1038/s41591-021-01402-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01402-w</ArticleId><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. . Characterising long COVID: a living systematic review. BMJ Global Health. (2021) 6:e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. . Risk factors associated with long COVID syndrome: a retrospective study. Iran J Med Sci. (2021) 46:428. 10.30476/ijms.2021.92080.2326</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, et al. . Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. (2022) 20:1&#x2013;12. 10.2139/ssrn.4020142</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4020142</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Gezondheidsmonitor volwassenen en ouderen . Public Health Service North and South Limburg. Heerlen: GGD Zuid Limburg en GGD Limburg-Noord. (2020).</Citation></Reference><Reference><Citation>Epidemiologische situatie van SARS-CoV-2 in Nederland . Rijksinstituur voor Volksgezondheid en Milieu (RIVM). Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu (RIVM). (2022).</Citation></Reference><Reference><Citation>Craig CL, Marshall AL, Sj&#xf6;str&#xf6;m M, Bauman AE, Booth ML, Ainsworth BE, et al. . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. (2003) 35:1381&#x2013;95. 10.1249/01.MSS.0000078924.61453.FB</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/01.MSS.0000078924.61453.FB</ArticleId><ArticleId IdType="pubmed">12900694</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Q Life Res. (2011) 20:1727&#x2013;36. 10.1007/s11136-011-9903-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher C. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ. (1960) 2:1665.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psych Res. (1994) 38:383&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">7965927</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herck M, Go&#xeb;rtz YM, Houben-Wilke S, Machado FV, Meys R, Delbressine JM, et al. . Severe fatigue in long COVID: web-based quantitative follow-up study in members of online long COVID support groups. J Med Internet Res. (2021) 23:e30274. 10.2196/30274</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30274</ArticleId><ArticleId IdType="pmc">PMC8457337</ArticleId><ArticleId IdType="pubmed">34494964</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnefski N, Kraaij V. The cognitive emotion regulation questionnaire. Eur J Psychol Assess. (2007) 23:141&#x2013;9. 10.1027/1015-5759.23.3.141</Citation><ArticleIdList><ArticleId IdType="doi">10.1027/1015-5759.23.3.141</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeschoten M, Bakker A, Jongedijk R, Olff M. PTSS checklist voor de DSM-5 (PCL-5). Unpublished manuscript. (2014). Available online at: https://www.psychotraumadiagnostics.centrum45.nl/nl/ptss.</Citation></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Internal Med. (2001) 16:606&#x2013;13. 10.1046/j.1525-1497.2001.016009606.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jong-Gierveld J, Kamphuls F. The development of a Rasch-type loneliness scale. Appl Psychol Measur. (1985) 9:289&#x2013;99.</Citation></Reference><Reference><Citation>Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. (1993) 4:353&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">10146874</ArticleId></ArticleIdList></Reference><Reference><Citation>Steijvers LC, Brinkhues S, Hoebe CJ, van Tilburg TG, Claessen V, Bouwmeester-Vincken N, et al. . Social networks and infectious diseases prevention behavior: a cross-sectional study in people aged 40 years and older. PLoS ONE. (2021) 16:e0251862. 10.1371/journal.pone.0251862</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251862</ArticleId><ArticleId IdType="pmc">PMC8133464</ArticleId><ArticleId IdType="pubmed">34010363</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J, Padilla S, Fern&#xe1;ndez-Gonz&#xe1;lez M, Garc&#xed;a JA, Agull&#xf3; V, Andreo M, et al. . Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study. J Clin Immunol. (2021) 41:1490&#x2013;501. 10.1007/s10875-021-01083-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01083-7</ArticleId><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Russell RM, Bibollet-Ruche F, Skelly AN, Sherrill-Mix S, Freeman DA, et al. . Early release-predictors of nonseroconversion after SARS-CoV-2 infection. Emerg Infect Dis. (2021) 27:2454. 10.3201/eid2709.211042</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2709.211042</ArticleId><ArticleId IdType="pmc">PMC8386781</ArticleId><ArticleId IdType="pubmed">34193339</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathela P, Crawley A, Weiss D, Maldin B, Cornell J, Purdin J, et al. . Seroprevalence of severe acute respiratory syndrome coronavirus 2 following the largest initial epidemic wave in the United States: findings from New York City, 13 May to 21 July 2020. J Infect Dis. (2021) 224:196&#x2013;206. 10.1093/infdis/jiab200</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab200</ArticleId><ArticleId IdType="pmc">PMC8083309</ArticleId><ArticleId IdType="pubmed">33836067</ArticleId></ArticleIdList></Reference><Reference><Citation>Self WH, Tenforde MW, Stubblefield WB, Feldstein LR, Steingrub JS, Shapiro NI, et al. . Decline in SARS-CoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network: 12 states, April&#x2013;August 2020. Morbidity Mortality Weekly Rep. (2020) 69:1762. 10.15585/mmwr.mm6947a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6947a2</ArticleId><ArticleId IdType="pmc">PMC7727600</ArticleId><ArticleId IdType="pubmed">33237893</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrie KJ, Faasse K, Crichton F, Grey A. How common are symptoms? Evidence from a New Zealand national telephone survey. BMJ Open. (2014) 4:e005374. 10.1136/bmjopen-2014-005374</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005374</ArticleId><ArticleId IdType="pmc">PMC4067867</ArticleId><ArticleId IdType="pubmed">24928596</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouter LM, Dongen MCJM, Zielhuis GA. Epidemiologisch Onderzoek: Opzet En Interpretatie. New York, NY: Springer; (2006). 10.1007/978-90-313-6527-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-90-313-6527-2</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>